Veerhealth Care Ltd.
| BSE: 511523 | Sector: Health care |
| NSE: NIYATILEAS | ISIN Code: INE882C01035 |
| BSE 00:00 | 20 May | 12.07 |
0.57 (4.96%) |
OPEN
10.93 |
HIGH
12.07 |
LOW
10.93 |
| NSE 05:30 | 01 Jan | Veerhealth Care Ltd |
| OPEN | 10.93 |
| PREVIOUS CLOSE | 11.50 |
| VOLUME | 1892 |
| 52-Week high | 18.98 |
| 52-Week low | 8.20 |
| P/E | 172.43 |
| Mkt Cap.(Rs cr) | 8 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Veerhealth Care Ltd. (NIYATILEAS) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Vista Pharma. | 6.81 | 2.41 | 25.06 | 0.11 | -0.63 | 0.00 | - |
| Panjon | 15.35 | 4.78 | 23.79 | 3.42 | 0.05 | 0.12 | 127.92 |
| Roopa Industries | 30.00 | 2.56 | 23.61 | 13.20 | 0.26 | 1.20 | 25.00 |
| Ortin Labs. | 26.05 | 5.89 | 21.18 | 13.16 | 0.44 | 1.06 | 24.58 |
| Phaarmasia | 30.00 | -0.50 | 20.49 | 3.87 | -0.73 | 0.00 | - |
| Ishita Drugs | 47.50 | -3.46 | 14.20 | 4.33 | 0.15 | 2.95 | 16.10 |
| Parmax Pharma | 37.55 | 4.31 | 14.04 | 2.89 | -0.52 | 0.00 | - |
| Colinz Labs | 29.00 | 1.40 | 13.25 | 1.59 | 0.09 | 0.72 | 40.28 |
| Pharmaids Pharma | 12.78 | 3.15 | 13.18 | 0.30 | 0.01 | 0.14 | 91.29 |
| Shukra Pharma. | 57.00 | -3.31 | 8.95 | 2.89 | 0.05 | 0.43 | 132.56 |
| Veerhealth Care | 12.07 | 4.96 | 8.36 | 2.65 | 0.17 | 0.07 | 172.43 |
| Welcure Drugs | 6.00 | 1.52 | 8.11 | 0.08 | 0.07 | 0.02 | 300.00 |
| Beryl Drugs | 9.14 | 1.56 | 4.63 | 3.22 | -0.10 | 0.00 | - |
| Hind.Bio Science | 3.72 | -4.86 | 3.81 | 0.24 | 0.00 | 0.00 | - |
Quick Links for Veerhealth Care:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
